by Raynovich Rod | Aug 26, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Rayno Biopharmaceutical Stocks- Including New Picks Another great day for biotech with most Rayno stocks in a rally mode with a bit of profit taking on Gilead Sciences(GILD) down 1%. Notable movers up on our core picks are: Alkermes (ALKS), Amgen (AMGN), Ariad (ARIA),...
by Raynovich Rod | Jun 9, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Update-1…. 45 Minutes Before the Close 6/9…Risk On Biotech stocks soared today right at the open after news of $3.9B Idenix deal news was out. The XBI was up 5.4% on good volume. The XBI is more equal weighted and sensitive to mid and small cap stock...
by Raynovich Rod | May 22, 2014 | 2024 Rayno Tools and Diagnostics Portfolio, Clinical Diagnostics and Tools
Update 11/24/14 Clinical Diagnostics and Tools Stocks Review Performance YTD and compared to 11/13 YTD Top winners YTD are: EXAS 104%, ILMN 71.4%, ABAX 36.8% Top Losers YTD are: NSTG 16.6%, RGDX 54%, VRML 30.9% but all were good trades. IWM at $117.4 See Performance...
by Raynovich Rod | Apr 1, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the...
by Raynovich Rod | Mar 31, 2014 | Biopharmaceuticals
Large Cap Biopharmaceutical Growth Stocks With the MoMo days over the next earnings cycle (Q1,Q2 2014) should give us better clarity on winners for 2014.On the last day of March all of these large caps rallied after a severe one week correction from 3/21-28. Watch...
by Raynovich Rod | Mar 26, 2014 | Biopharmaceuticals
(See Full Article in Seeking Alpha 3/26) Biopharmaceutical Downdraft 15% From February Highs (IBB$239) Large Cap Biopharmaceutical Stocks Are Core Holdings: ABBV, AMGN, GILD The biotech frenzy of MoMo investing is over so it is time to invest longer term with quality...
by Raynovich Rod | Jan 23, 2014 | Biopharmaceuticals
Two Large Cap Pharmas Are Now Biotech Stocks: Abbvie, Inc. (ABBV) and Bristol -Myers Squibb (BMY) On our last post on the subject we postulated a model that the bull market in biotechnology would ride with the large cap leaders because they are perceived as growth...
by Raynovich Rod | Jan 17, 2014 | Biopharmaceuticals
J.P.Morgan Healthcare Conference Update #3 IBB ($248) New High Today at $249.50 Up 9% YTD–Fidelity Select Biotech (FBIOX) New All time High of $205.85 Up 19% since Dec.18!!! Trading Opportunities-Recovery from Bottom or “Dead Cat” Bounce? Achillion...
by Raynovich Rod | Nov 29, 2013 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Biotechnology Stocks Hits New Highs After A Choppy 60 Days Biotechnology stocks eked out small gains today taking the liquid $4.4B market cap ETF (IBB) to new highs at $225 up 5.58% for the week and 5.94% for the month of November.The $1B market cap ETF (XBI $130.49)...
by Raynovich Rod | Nov 15, 2013 | 2024 Rayno Biopharmaceuticals Portfolio
Vertex (VRTX $67) Contrarian Trade Working Vertex is one of the worse performing large cap biotechs over 6 mos. is getting boosted on a $152M royalty deal. “Risk-On “Mode in Biotech Stocks Biotech stocks continue to find buyers with the IBB ($211.70)...